Peter Clausi
-
Peter Clausi on CBLT declaring a dividend and on its Shatford Lake, Manitoba, exploration for lithium
In a recent InvestorIntel interview, Tracy Weslosky spoke with Peter Clausi, President, CEO and Director of CBLT Inc. (TSXV: CBLT)…
-
Fission 3.0’s Dev Randhawa on the Uranium Boomlet
In a recent InvestorIntel interview, Peter Clausi spoke with Dev Randhawa, Chairman and CEO of Fission 3.0 Corp.…
-
Thomas Smeenk with an update on the FDA Phase II clinical trial program of the Hemostemix blood-derived, stem cell therapeutics product (ACP-01)
In a recent InvestorIntel interview, Peter Clausi speaks with Thomas Smeenk, Co-Founder, President and CEO of Hemostemix Inc. (TSXV:…
-
Dev Randhawa on Fission 3.0 and why ESG Investors are looking at Uranium
In a recent InvestorIntel interview, Peter Clausi speaks with Dev Randhawa, Chairman and CEO of Fission 3.0 Corp.…
-
Brendon Grunewald on rising demand for Moovly’s cloud-based video tools and the partnerships driving sales forward
In a recent InvestorIntel interview with host Peter Clausi, Brendon Grunewald CEO and Director of Moovly Media Inc.…
-
Hugh Rogers on the European approval of the XPhyto Therapeutics point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system
In a recent InvestorIntel interview, Peter Clausi spoke with Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp. (CSE:…
